Topic Progress:

Traumatic brain injury (TBI) is a form of acquired brain injury that occurs when a sudden trauma causes damage to the brain.

TBI is the commonest cause of coma and the leading cause of death in those under 45.

300-400 per 100,000 in high income countries REF

Large global variation 60 to 811 per 100 000

Incidence increasing in low income countries with increased road usage and lower safety standards

Incidence increasing in high income countries due to falls in elderly patients

Australian figures are 275 per 100,000 REF

This compares with aSAH c.10/100000, ICH c.10/100000 person years, AIS c.100/100,000

Globally 69 million individuals are estimated to suffer TBI from all causes each year REF

Incidence peaks in the 0-4 year olds, young men and then significantly in the elderly:

REFERENCE

CLASSIFICATION

There are several ways to classify TBI.

All give some idea about prognosis.

Understanding the pathophysiology of Secondary Brain Injury is most useful in terms of critical care management.

MILD: GCS 14-15 (81%)

MOD: GCS 9-13 (11%)

SEVERE: GCS 3-8 (8%)

Direct Impact

Penetrating injury

Rapid acceleration and deceleration

Blast Injury

Often the focus of the SURGICAL MANAGEMENT

Affects prognosis

FOCAL PATHOLOGY

> Extradural haematoma (EDH)

> Subdural haematoma (SDH)

> IntraCerebral Haemorrhage (ICH) AKA haemorrhagic contusion AKA intraparenchymal haematoma

> Subarachnoid haemorrhage (SAH)

> Intra-ventricular haemorrhage (IVH)

NON-FOCAL PATHOLOGY

> Global ischaemia

> Diffuse Axonal Injury

> Diffuse brain swelling

> Post-traumatic hydrocephalus

PRIMARY BRAIN INJURY

Injuries caused by the trauma, causing neuronal ischaemia and death

Determined by the initial impact so can’t really be influenced by what we do

SECONDARY BRAIN INJURY

> The focus of the critical care management

> Because some causes are modifiable

SYSTEMIC

> Hypoxia

> Hypo- and hypercapnoea

> Hyperthermia (fever)

> Hypo- and hyperglycaemia

> Hypo- and hypernatraemia

> Hyperosmolality

> Non-CNS infection / sepsis

INTRACRANIAL

> Seizures

> Delayed bleed / haematoma

> Effects of SAH

> Vasospasm

> Hydrocephalus

> CNS infection

> Paroxysmal sympathetic hyperactivity

CLINICALLY RELEVANT PATHOPHYSIOLOGY

> The brain is enclosed within the rigid skull and dura

> Small increases in intracranial volume result in sharp increases in intracranial pressure: The Monroe-Kelly doctrine

See section on EICP Fundamentals

> TBI invokes and inflammatory response characterised by the release of pro- and anti-inflammatory mediators

> This response alters the permeability of the blood-brain barrier (BBB), causes glial swelling and alters global and regional cerebral blood flow

> Altered BBB permeability can change response to IV fluids, osmotic diuretics and vasoactive drugs

REF

Normally, cerebral perfusion is maintained at a constant rate in the presence of changing perfusion pressures by regional myogenic and metabolic autoregulation

When these mechanisms are damaged in TBI 3 patterns of cerebral blood flow (CBF) follow:

CBF reduced by extrinsic and intrinsic mechanisms

Autoregulation impaired so CBF depends on / correlates with systemic blood pressure

Cytotoxic oedema caused by neuronal ischaemia, common in 1st 24h after SDH and contusions AND

Vasogenic oedema from BBB damage and leak, common in perilesional regions. 

Most prominent next to contusions and underlying SDHs and are true ischemia rather than appropriately coupled hypoperfusion in regions of low metabolic demand


> When autoregulation mechanisms start to recover, CBF improves

> Cerebral hyperaemia is seen which may cause EICP

> May last 7-10 days

> Occurs in 25-30% of patients


Late cerebral blood flow reduction often seen

Not as pronounced as initial reduction in CBF

Can be associated with vasospasm


These are generalised phenomena that are seen, and there is significant variation between patients

This is covered in the Elevated Intracranial Pressure Module

TBI is the classic model for EICP and the principles described there all apply to severe TBI patients.

Secondary injury mechanisms include:

  • Excitotoxicity
  • Calcium influx
  • Oxidative injury (through lipid peroxidation, protein nitrosylation, and DNA damage)
  • Cellular and humoral inflammatory mediators
  • Energy failure

Which result in secondary neuronal loss through a range of cell death modes (necrosis, apoptosis, necroptosis, paraptosis, parthanosis, autophagy, and phagoptosis of injured but viable cells by activated microglia).

Cytotoxic edema may arise from either reduced energy supply or increased energy demand.

Systemic hypoxia and hypotension are important causes of inadequate oxygen and substrate delivery, and powerful modulators of outcome

Even if systemic physiology is maintained, classic ischemia is seen, commonly within the first 24 hours after TBI and often in relation to contusions and SDHs.

Other factors that impair energy generation include:

  • Tissue hypoxia arising from impaired oxygen diffusion
  • Microvascular ischemia
  • Mitochondrial dysfunction causing metabolic crisis

Mitochondrial dysfunction may be due to mechanical disruption of mitochondria, or due to competitive inhibition in the respiratory chain by elevated levels of nitric oxide.

These energy crises can be measured locally with cerebral microdialysis, a form of invasive neuromonitoring used mainly in research centres.

REF

Cortical spreading depression (CSD) is increasingly recognised pathologic process following TBI

CSD is a physiologic phenomenon characterized by transient cortical gray matter depolarization that expands to adjacent regions at a rate of 2–5 mm/min, resulting in suppression of spontaneous electrical activity for a period of several minutes.

Detectable on electroencephalography, this “silencing” of brain activity is thought to underlie the metabolic disruption and redistribution of ions characteristic of CSD.

This includes neuronal K+ efflux and Ca2+ influx, glutamatergic neurotransmission, and astrocyte-mediated cerebral blood flow (CBF) modulation.

The ensuing metabolic crisis ultimately contributes to the delayed secondary insults following TBI.

With improvements in electrocorticography (ECoG) and intracranial electroencephalography approaches, real-time cortical monitoring has become more clinically feasible.

Further understanding CSD in TBI may provide a new treatment paradigm in managing TBI. REF

More on CSD

There is good evidence that an individual’s genetics affect their recovery following TBI.

There are many challenges to examining the genetic basis of recovery from brain injury in humans, and the results of many studies performed to date are not really conclusive.

BDNF and APOE gene loci have been thought to be involved in recovery from TBI or stroke

Genome wide Association Studies have not confirmed this however but have brought forward new candidates that require validation and further analysis.

A complicated and developing area of research. Read more here.

Log in with your credentials

Forgot your details?